Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −1,172−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q1 2025 | 17,577 | $12.0K | <0.1% | −100−0.6% | Reduced | Holders |
| Q4 2024 | 17,677 | $16.4K | <0.1% | +4,733+36.6% | Added | Holders |
| Q3 2024 | 12,944 | $16.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 12,944 | $16.1K | <0.1% | −318−2.4% | Reduced | Holders |
| Q1 2024 | 13,262 | $12.4K | <0.1% | −270−2.0% | Reduced | Holders |
| Q4 2023 | 13,532 | $7.65K | <0.1% | −24,510−64.4% | Reduced | Holders |
| Q3 2023 | 38,042 | $22.7K | <0.1% | −894−2.3% | Reduced | Holders |
| Q2 2023 | 38,936 | $22.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 38,936 | $27.4K | <0.1% | −1,850−4.5% | Reduced | Holders |
| Q4 2022 | 40,786 | $92.2K | <0.1% | −116,392−74.1% | Reduced | Holders |
| Q3 2022 | 157,178 | $503.0K | <0.1% | −17,776−10.2% | Reduced | Holders |
| Q2 2022 | 174,954 | $665.0K | <0.1% | −57,087−24.6% | Reduced | Holders |
| Q1 2022 | 232,041 | $1.25M | <0.1% | −316,232−57.7% | Reduced | Holders |
| Q4 2021 | 548,273 | $7.41M | <0.1% | −95,200−14.8% | Reduced | Holders |
| Q3 2021 | 643,473 | $11.6M | <0.1% | +242,771+60.6% | Added | Holders |
| Q2 2021 | 400,702 | $6.88M | <0.1% | −102,011−20.3% | Reduced | Holders |
| Q1 2021 | 502,713 | $10.1M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.